ReviewCurrent oncology (Toronto, Ont.)2022

Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

Jong Chul Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.